|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cutaneous Leishmaniasis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leishmaniasis | |||||
| Leishmaniasis, Cutaneous | |||||
| 3 | More general conditions related to this trial | ||||
| Mastigophora Infections | |||||
| Parasitic Diseases | |||||
| Protozoan Infections | |||||
| Sarcomastigophora Infections | |||||
| Skin Diseases | |||||
| Skin Diseases, Infectious | |||||
| Skin Diseases, Parasitic | |||||
| 4 | Sponsors listed in this trial | ||||
| Allermed Laboratories, Inc. | |||||
| U.S. Army Medical Research and Materiel Command | |||||